AGD1/USP10/METTL13 Complexes Enhance Cancer Stem Cells Proliferation and Diminish the Therapeutic Effect of Docetaxel via CD44 m6A Modification in Castration Resistant Prostate Cancer

0
428
The authors demonstrated that AGD1, derived from prostate cancer stem cells, enhanced the stemness of prostate cancer cells and reduced the therapeutic effect of docetaxel in castration-resistant prostate cancer.
[Journal of Experimental & Clinical Cancer Research]
Full Article